📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Insys Therapeutics

1.1 - Company Overview

Insys Therapeutics Logo

Insys Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceuticals, developing and commercializing innovative supportive care products.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Insys Therapeutics

Amgen Logo

Amgen

HQ: United States Website
  • Description: Provider of biotechnology-based human therapeutics, including biosimilar medicines for oncology, hematology, and chronic inflammatory diseases, and oncology therapies spanning precision oncology and targeted immunotherapy. Also offers the Amgen Biotech Experience for hands-on secondary school education and supports science education and communities through the Amgen Foundation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amgen company profile →
Polichem Logo

Polichem

HQ: Switzerland Website
  • Description: Provider of tools and knowledge to improve the health of patients worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Polichem company profile →
ZymoGenetics Logo

ZymoGenetics

HQ: United States Website
  • Description: Provider of therapeutic protein discovery, development, and early manufacturing, supported by fully integrated research and development capabilities in scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, and clinical expertise; with an early focus on production systems for recombinant proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ZymoGenetics company profile →
CoGenesys Logo

CoGenesys

HQ: United States Website
  • Description: Provider of peptide- and protein-based medicine development for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CoGenesys company profile →
Questcor Pharmaceuticals Logo

Questcor Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical treatments for serious, difficult-to-treat autoimmune and inflammatory disorders, focused on neurology and nephrology, and supporting research efforts in a variety of conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Questcor Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Insys Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Insys Therapeutics

2.2 - Growth funds investing in similar companies to Insys Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Insys Therapeutics

4.2 - Public trading comparable groups for Insys Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Insys Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Insys Therapeutics

What does Insys Therapeutics do?

Insys Therapeutics is a provider of specialty pharmaceuticals, developing and commercializing innovative supportive care products.

Who are Insys Therapeutics's competitors?

Insys Therapeutics's competitors and similar companies include Amgen, Polichem, ZymoGenetics, CoGenesys, and Questcor Pharmaceuticals.

Where is Insys Therapeutics headquartered?

Insys Therapeutics is headquartered in United States.

How many employees does Insys Therapeutics have?

Insys Therapeutics has 1,000 employees 🔒.

When was Insys Therapeutics founded?

Insys Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Insys Therapeutics in?

Insys Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Insys Therapeutics

Who are the top strategic acquirers in Insys Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Insys Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Insys Therapeutics?

Top strategic M&A buyers groups and sectors for Insys Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Insys Therapeutics's sector and industry vertical

Which are the top PE firms investing in Insys Therapeutics's sector and industry vertical?

Top PE firms investing in Insys Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Insys Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Insys Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Insys Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Insys Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Insys Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Insys Therapeutics?

The key public trading comparables and valuation benchmarks for Insys Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Insys Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Insys Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Insys Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Insys Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Insys Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Insys Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Insys Therapeutics